Who Paid My Doc
Spi-Gcf-302
Research payments
$49,444
Through program year 2019, $49,444 in research payments was reported against Spi-Gcf-302, across 37 payments, paid by Spectrum Pharmaceuticals Inc..
- Paid by
- Spectrum Pharmaceuticals Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $49,444 | 37 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Lasika Seneviratne Los Angeles, CA Named on 3 payments
- Andrew Delmas Fort Gordon, GA Named on 2 payments
- Jason Tache Tamarac, FL Named on 2 payments
- Michael McLaughlin Denver, CO Named on 2 payments
- Robert Swaney Broomfield, CO Named on 2 payments
- Jawad Francis Warren, OH Named on 2 payments
- Alvaro Restrepo Dallas, TX Named on 2 payments
- Haresh Jhangiani Fountain Valley, CA Named on 1 payment
- Lee Schwartzberg Memphis, TN Named on 1 payment
- Hirva Mamdani Troy, MI Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.